- Home
- DVA vs CAVA Comparison
DVA vs CAVA Comparison
Compare DVA & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- CAVA
- Stock Information
- Founded
- DVA 1994
- CAVA 2006
- Country
- DVA United States
- CAVA United States
- Employees
- DVA N/A
- CAVA N/A
- Industry
- DVA Misc Health and Biotechnology Services
- CAVA Restaurants
- Sector
- DVA Health Care
- CAVA Consumer Discretionary
- Exchange
- DVA Nasdaq
- CAVA Nasdaq
- Market Cap
- DVA 9.7B
- CAVA 10.0B
- IPO Year
- DVA 1995
- CAVA 2023
- Fundamental
- Price
- DVA $137.82
- CAVA $66.63
- Analyst Decision
- DVA Hold
- CAVA Buy
- Analyst Count
- DVA 2
- CAVA 15
- Target Price
- DVA $162.00
- CAVA $102.80
- AVG Volume (30 Days)
- DVA 701.0K
- CAVA 6.4M
- Earning Date
- DVA 10-28-2025
- CAVA 08-12-2025
- Dividend Yield
- DVA N/A
- CAVA N/A
- EPS Growth
- DVA 8.72
- CAVA 213.93
- EPS
- DVA 10.20
- CAVA 1.18
- Revenue
- DVA $13,161,328,000.00
- CAVA $1,083,653,000.00
- Revenue This Year
- DVA $5.96
- CAVA $25.04
- Revenue Next Year
- DVA $3.54
- CAVA $21.66
- P/E Ratio
- DVA $13.47
- CAVA $56.49
- Revenue Growth
- DVA 5.09
- CAVA 28.21
- 52 Week Low
- DVA $126.07
- CAVA $65.03
- 52 Week High
- DVA $179.60
- CAVA $172.43
- Technical
- Relative Strength Index (RSI)
- DVA 51.25
- CAVA 35.52
- Support Level
- DVA $135.04
- CAVA $65.04
- Resistance Level
- DVA $137.29
- CAVA $68.91
- Average True Range (ATR)
- DVA 2.88
- CAVA 2.21
- MACD
- DVA 0.26
- CAVA 0.15
- Stochastic Oscillator
- DVA 54.32
- CAVA 29.16
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.